| Ace-K | Acesulfame-potassium |
| CCK | Cholecystokinin |
| CHD | Congenital heart defect |
| EEC | Enteroendocrine cells |
| FDA | Food and Drug Administration |
| GI | Gastrointestinal |
| GLP-1 | Glucagon-like peptide-1 |
| GLUT2 | Glucose transporter-2 |
| GPCR | G protein coupled receptor |
| GRAS | Generally recognized as safe |
| IBD | Inflammatory bowel disease |
| IEC | Intestinal epithelial cell |
| IR | insulin receptor |
| LPS | Lipopolysaccharide |
| miRNA | MicroRNA |
| MMP9 | Matrix metalloproteinase-9 |
| NAS | Noncaloric artificial sweeteners |
| Neu-1 | Neuraminidase-1 |
| NHLBI | National Heart, Lung and Blood Institute |
| NNS | Non-nutritive sweeteners |
| NOD | Nucleotide oligomerization domain |
| PDE | Phosphodiesterase |
| PLCβ2 | Phospholipase Cβ2 |
| PYY | Peptide YY |
| rEM | Rapid evidence mapping |
| SCFA | Short-chain fatty acid |
| SGLT-1 | Sodium-glucose co-transporter-1 |
| T1R | Taste 1 receptor |
| T2DM | Type 2 diabetes mellitus |
| T2R | Taste 2 receptor |
| TCR | Taste receptor cell |
| TRPM5 | Transient receptor potential cation channel subfamily M member 5 |